Suppr超能文献

隐匿性肝病负担:来自大型全科医生数据库的分析。

Occult liver disease burden: Analysis from a large general practitioners' database.

作者信息

Martini Andrea, Ceranto Elena, Gatta Angelo, Angeli Paolo, Pontisso Patrizia

机构信息

Internal Medicine and Hepatology, Regional Referral Center for Liver Disease, Department of Medicine, University of Padua, Italy.

出版信息

United European Gastroenterol J. 2017 Nov;5(7):982-986. doi: 10.1177/2050640617696402. Epub 2017 Feb 26.

Abstract

BACKGROUND

Cirrhosis represents the end stage of chronic liver disease, characterized by high mortality and morbidity. The prevalence of liver disease is difficult to assess, given its clinical latency up to the late stage.

OBJECTIVE

We aimed to assess the prevalence of unrecognized chronic liver disease and cirrhosis using surrogate indicators from medical records of family physicians.

METHODS

Medical records of 139,104 subjects, collected from 99 family physicians of the Veneto region, were used. Persistently high transaminases were used as indicators of occult chronic liver disease; thrombocytopenia, unrelated to haematological malignancies, was used as indicator of occult cirrhosis. Diagnosis of chronic liver disease and cirrhosis was assessed using ICD9-CM-1997 codes.

RESULTS

Alteration of transaminases was found in 32.7% of the subjects, and among them only one-third had an already diagnosed liver disease. Patients with diagnosis of cirrhosis were 0.3%, while thrombocytopenia, indicator of occult cirrhosis, was detected in 1.3% of the remaining population. Patients with overt and occult cirrhosis showed a higher metabolic profile, with significantly higher prevalence of arterial hypertension, obesity and diabetes than the general population.

CONCLUSION

A large proportion of patients with chronic liver disease is still undiagnosed. Surrogate biochemical indicators might be useful for disease recognition.

摘要

背景

肝硬化是慢性肝病的终末期,具有高死亡率和高发病率。鉴于肝病在晚期之前存在临床潜伏期,其患病率难以评估。

目的

我们旨在使用家庭医生病历中的替代指标评估未被识别的慢性肝病和肝硬化的患病率。

方法

使用从威尼托地区99名家庭医生收集的139104名受试者的病历。持续高转氨酶用作隐匿性慢性肝病的指标;与血液系统恶性肿瘤无关的血小板减少用作隐匿性肝硬化的指标。使用ICD9-CM-1997编码评估慢性肝病和肝硬化的诊断。

结果

32.7%的受试者发现转氨酶异常,其中只有三分之一已被诊断患有肝病。肝硬化诊断患者为0.3%,而在其余人群中1.3%检测到隐匿性肝硬化指标血小板减少。显性和隐匿性肝硬化患者表现出更高的代谢特征,动脉高血压、肥胖和糖尿病的患病率明显高于普通人群。

结论

很大一部分慢性肝病患者仍未被诊断。替代生化指标可能有助于疾病识别。

相似文献

1
Occult liver disease burden: Analysis from a large general practitioners' database.
United European Gastroenterol J. 2017 Nov;5(7):982-986. doi: 10.1177/2050640617696402. Epub 2017 Feb 26.
2
Electronic sanitary database: a new potential tool to identify occult chronic liver disease in general population.
Intern Emerg Med. 2024 Apr;19(3):641-647. doi: 10.1007/s11739-023-03507-1. Epub 2024 Jan 16.
3
Occult cirrhosis diagnosed by transient elastography is a frequent and under-monitored clinical entity.
Liver Int. 2015 Oct;35(10):2285-93. doi: 10.1111/liv.12802. Epub 2015 Mar 4.
5
NASH-RELATED CIRRHOSIS: AN OCCULT LIVER DISEASE BURDEN.
Hepatol Commun. 2017 Apr;1(2):84-86. doi: 10.1002/hep4.1033. Epub 2017 Apr 6.
6
Prevalence and prediction of coronary artery disease in patients with liver cirrhosis: a registry-based matched case-control study.
Circulation. 2014 Oct 14;130(16):1353-62. doi: 10.1161/CIRCULATIONAHA.114.009278. Epub 2014 Aug 5.
9
Significance of Occult Hepatitis C Virus Infection in Liver Transplant Patients With Cryptogenic Cirrhosis.
Exp Clin Transplant. 2020 Apr;18(2):206-209. doi: 10.6002/ect.2017.0332. Epub 2018 Oct 19.
10
Incidence, aetiology and related comorbidities of cirrhosis: a Swedish population-based cohort study.
BMC Gastroenterol. 2020 Apr 3;20(1):84. doi: 10.1186/s12876-020-01239-6.

引用本文的文献

1
Electronic sanitary database: a new potential tool to identify occult chronic liver disease in general population.
Intern Emerg Med. 2024 Apr;19(3):641-647. doi: 10.1007/s11739-023-03507-1. Epub 2024 Jan 16.
2
MELD-Na Score as a Predictor of Postoperative Complications in Ventral Skull Base Surgery.
J Neurol Surg B Skull Base. 2022 Jul 18;84(4):405-412. doi: 10.1055/a-1842-8668. eCollection 2023 Aug.
3
Undiagnosed abnormal alanine transaminase levels in vulnerable populations: Impact of sex, race/ethnicity, and body mass.
Obes Sci Pract. 2022 Sep 16;9(2):190-199. doi: 10.1002/osp4.634. eCollection 2023 Apr.
4
Metformin-Associated Lactic Acidosis in a Diabetic Patient with Normal Kidney Function and Occult Cirrhosis.
Case Rep Crit Care. 2022 Oct 5;2022:5506744. doi: 10.1155/2022/5506744. eCollection 2022.
6
Burden of nonalcoholic fatty liver disease in Canada, 2019-2030: a modelling study.
CMAJ Open. 2020 Jun 9;8(2):E429-E436. doi: 10.9778/cmajo.20190212. Print 2020 Apr-Jun.
7
A practical clinical approach to liver fibrosis.
Singapore Med J. 2018 Dec;59(12):628-633. doi: 10.11622/smedj.2018145.

本文引用的文献

1
Squamous cell carcinoma antigen-IgM is associated with hepatocellular carcinoma in patients with cirrhosis: A prospective study.
Dig Liver Dis. 2016 Feb;48(2):197-202. doi: 10.1016/j.dld.2015.10.022. Epub 2015 Oct 31.
3
Nonalcoholic fatty liver disease: a systematic review.
JAMA. 2015 Jun 9;313(22):2263-73. doi: 10.1001/jama.2015.5370.
5
The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis.
PLoS One. 2014 Jul 2;9(7):e101554. doi: 10.1371/journal.pone.0101554. eCollection 2014.
6
Liver cirrhosis.
Lancet. 2014 May 17;383(9930):1749-61. doi: 10.1016/S0140-6736(14)60121-5. Epub 2014 Jan 28.
7
Development and validation of a comorbidity scoring system for patients with cirrhosis.
Gastroenterology. 2014 Jan;146(1):147-56; quiz e15-6. doi: 10.1053/j.gastro.2013.09.019. Epub 2013 Sep 18.
8
The burden of liver disease in Europe: a review of available epidemiological data.
J Hepatol. 2013 Mar;58(3):593-608. doi: 10.1016/j.jhep.2012.12.005.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验